The impact of salary level on the diagnosis and treatment of children with cow's milk protein allergy: a prospective observational cross-sectional study

• Autor(a) principal: Motta, Mariana Bayona
• Data de Publicação: 2022
• Outros Autores: Costa, João Lucas Morete Caieiro da, Bonini, Luca Campassi, Marques, Rafael Ito, Queiroz, Vítor Pio de, Marini, Karina Dupim, Barrionuevo, Juliana Spir, Rodrigues, Carolina Santos
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: MedNEXT Journal of Medical and Health Sciences
• Texto Completo: https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/229
• topic: Cow's milk protein allergy; Allergy; Treatment; Diagnosis; Income; Supplementation

Cow's milk protein allergy (CMPA) is a type of food allergy (FA), that is, a reaction of the immune system in the gastrointestinal tract due to the ingestion of proteins such as beta-lactoglobulin, alphalactalbumin, and casein. This condition most substantially affects children in the early stages of their development, about 2% of the American child population, and, consequently, directly or indirectly influences the families of each of them. In the Brazilian context, the epidemiological analysis is shallow in quantitative and qualitative data. Because of this, this study aims to understand the path of patients with CMPA, from diagnosis to treatment, and how their income and their knowledge of their rights in the Unified Health System interfere throughout this process. A form was used as a method to collect data from families with CMPA patients, accounting for 107 in all, which were consulted through online communities. Facing the financial and nutritional challenges of treating a child with CMPA and, at the same time, with the results obtained, the authors of this study were able to verify that, despite the high cost of adapting the diet of this AA, the economic factor was not it was relevant within this consulted microcosm regarding treatment, but slightly influential in the diagnosis. Analyzing the knowledge of the benefit offered by SUS concerning the child's nutritional supplementation, it was possible to verify that, of a total of 44 people, about 45%, know the benefit, but do not use it, and do not perform the supplementation. So, for this and other obtained relations, the study concluded that low income is not a limiting factor for the treatment of patients with CMPA, being slightly influential in the way in which families seek the diagnosis of this FA. In line with this view, it was possible to note the high evasion of SUS Primary Care and the non-use of the formulas offered, although they are sometimes known by the target audience.